At the end of December 2019, “pneumonia of unknown cause” occurred Later, the specialized cause was identified and coined as Severe Respiratory Disorders Coronavirus 2 (SARS-CoV-2), and the disease was named “Coronavirus Disease 2019” (COVID-19). This recent new pollution brought the world to a standstill in a short period of time. On March 11, 2020, the WHO announced that the novel coronavirus disease is widespread. Analysts from around the world are coming together to study the pathogenicity and transmissibility of SARS-CoV-2 and derive treatments to curb this contamination. Analysts and researchers are implementing a unique expression of medicine in a comprehensive journey to find safer ways to control the obsessive effects of this viral infection. Numerous clinical studies are currently underway in the allopathic and naturopathy sector. Furthermore, global approaches to cell therapy and nanomedicine practices need to be optimized to obtain better clinical outcomes and useful results. Additionally, paradigm shifts in cell therapy and nanomedicine protocols will need to be optimized to achieve better clinical and functional outcomes for individuals affected by COVID-19. This article provides a comprehensive overview of the pathogenesis of the outbreak and various treatments to combat COVID-19.
No takes yet. Share an insight, caveat, or question.
Ghazizadeh et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: